B. Metzler seel. Sohn & Co. AG Buys 13,065 Shares of Cardinal Health, Inc. $CAH

Key Points

• B. Metzler seel. Sohn & Co. AG increased its stake in Cardinal Health, Inc. by 112.8%, acquiring an additional 13,065 shares, bringing their total holdings to 24,646 shares worth approximately $3.4 million.
• CEO Jason M. Hollar sold 107,705 shares of Cardinal Health at an average price of $148.90, reducing his position by 31.35% to 235,901 shares valued at about $35.1 million.
• Cardinal Health's quarterly earnings exceeded analysts' expectations, reporting $2.08 EPS, beating the estimate of $2.03, and the company has set its FY 2026 EPS guidance between 9.300-9.500.

B. Metzler seel. Sohn & Co. AG lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 112.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 24,646 shares of the company's stock after buying an additional 13,065 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Cardinal Health were worth $3,395,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Wellington Management Group LLP lifted its holdings in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. Castlekeep Investment Advisors LLC purchased a new position in Cardinal Health in the 4th quarter worth about $141,963,000. JPMorgan Chase & Co. boosted its holdings in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. GAMMA Investing LLC grew its stake in shares of Cardinal Health by 17,589.1% in the first quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock worth $132,940,000 after acquiring an additional 959,486 shares during the period. Finally, Junto Capital Management LP purchased a new position in shares of Cardinal Health during the fourth quarter valued at approximately $92,811,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Cardinal Health

In related news, insider Michelle D. Greene sold 13,500 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider directly owned 14,976 shares of the company's stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock valued at $40,489,525 in the last 90 days. 0.09% of the stock is currently owned by insiders.

Cardinal Health Stock Up 0.8%

CAH stock traded up $1.18 during midday trading on Tuesday, hitting $149.96. The company's stock had a trading volume of 923,476 shares, compared to its average volume of 2,420,887. The firm has a market capitalization of $35.81 billion, a price-to-earnings ratio of 23.27, a price-to-earnings-growth ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 12 month low of $106.54 and a 12 month high of $168.44. The company has a 50 day moving average of $157.10 and a two-hundred day moving average of $146.46.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health's quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's payout ratio is currently 31.63%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Bank of America raised their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Leerink Partners cut their price objective on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a report on Tuesday, August 12th. UBS Group reissued a "buy" rating on shares of Cardinal Health in a report on Tuesday, August 12th. Citigroup reaffirmed a "neutral" rating and set a $170.00 price target (up previously from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Finally, Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.